A Study of Ivonescimab in People With Leiomyosarcoma

Full Title

Ivonescimab for the Treatment of Previously Treated Advanced or Unresectable Leiomyosarcoma - A Phase II Trial

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Sandra D’Angelo’s office at 646-888-4159.

Protocol
26-011
Phase
Phase II (phase 2)
Investigator
Sandra P. D'Angelo
Co-Investigators
Sujana Movva
Diseases
Sarcomas › Leiomyosarcoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07516925
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description